Evaluating the prevalence and severity of NAFLD in primary care: the EPSONIP study protocol

Evaluating the prevalence and severity of NAFLD in primary care: the EPSONIP study protocol

Abstract Background Non-alcoholic fatty liver disease (NAFLD) affects 20–30% of the general adult population. NAFLD patients with type 2 diabetes mellitus (T2DM) are at an increased risk of advanced fibrosis, which puts them at risk of cardiovascular complications, hepatocellular carcinoma, or liver...

Full description

Bibliographic Details
Main Authors: Patrik Nasr, Fredrik Iredahl, Nils Dahlström, Karin Rådholm, Pontus Henriksson, Gunnar Cedersund, Olof Dahlqvist Leinhard, Tino Ebbers, Joakim Alfredsson, Carl-Johan Carlhäll, Peter Lundberg, Stergios Kechagias, Mattias Ekstedt
Format: Article
Language:English
Published: BMC 2021-04-01
Series:BMC Gastroenterology
Subjects:
Non-alcoholic fatty liver disease
Type 2 diabetes mellitus
T2DM
Cirrhosis
Biomarkers
Online Access:https://doi.org/10.1186/s12876-021-01763-z

Internet

https://doi.org/10.1186/s12876-021-01763-z

Similar Items